法国经导管主动脉瓣置换术的实施现状
基于法国2007至2015年住院出院数据库,共收集131,251例主动脉瓣置换术,其中外科主动脉瓣置换术109,317例(83%),经导管主动脉瓣置换术21,934例(17%)。主动脉瓣置换术总量线性增长(从10,892例增至18,704例,趋势P<0.0001),主要因经导管主动脉瓣置换术大幅增加(从244例增至6,722例,趋势P=0.0004),而外科主动脉瓣置换术保持稳定(从10,892例增至11,982例,趋势P=0.18)。经导管主动脉瓣置换术在2015年占所有主动脉瓣置换术的三分之一,且在医院内死亡率方面,在75岁以上患者中与孤立外科主动脉瓣置换术相比具有优势。
要点
- 2007至2015年法国主动脉瓣置换术总量增长主要源于经导管主动脉瓣置换术的广泛应用。
- 经导管主动脉瓣置换术在2015年占所有主动脉瓣置换术的三分之一。
- 在75岁以上患者中,经导管主动脉瓣置换术的院内死亡率与孤立外科主动脉瓣置换术相似或略低。
核心结论
- 2007至2015年间法国主动脉瓣置换术数量显著增加,主要归因于经导管主动脉瓣置换术的广泛采用,2015年经导管主动脉瓣置换术占所有主动脉瓣置换术的三分之一。
- 患者临床特征改善,提示患者转诊更早,且所有主动脉瓣置换术亚组的院内死亡率均下降。
- 尽管临床特征更差,75岁以上患者经导管主动脉瓣置换术的即刻结局与孤立外科主动脉瓣置换术相比具有优势。
研究设计与样本
- 基于法国行政住院出院数据库的回顾性研究,收集2007至2015年间法国所有连续主动脉瓣置换术。
- 共纳入131,251例干预,其中外科主动脉瓣置换术109,317例(83%),经导管主动脉瓣置换术21,934例(17%)。
主要发现
- 主动脉瓣置换术总量线性增加(从10,892例增至18,704例;趋势P<0.0001),主要因经导管主动脉瓣置换术增加(从244例增至6,722例;趋势P=0.0004),外科主动脉瓣置换术保持稳定(从10,892例增至11,982例;趋势P=0.18)。
- Charlson指数下降(趋势P<0.05),外科主动脉瓣置换术和经导管主动脉瓣置换术的院内死亡率均显著下降(趋势P<0.01)。
- 经导管主动脉瓣置换术在所有年龄组(<75、75-79、80-84、≥85岁)均显著增加(趋势P=0.003),但在两个最老年龄组达到或超过外科主动脉瓣置换术。
- 2015年,在三个最老年龄组中,经导管主动脉瓣置换术的死亡率与孤立外科主动脉瓣置换术相似或略低,但未达统计学显著性(P=0.66、P=0.47、P=0.06)。
临床怎么用
- 经导管主动脉瓣置换术的广泛采用显著增加了主动脉瓣置换术的总量,尤其在老年人群中。
- 对于75岁以上患者,经导管主动脉瓣置换术的院内结局与孤立外科主动脉瓣置换术相当或更优,支持其在该人群中的应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Transcatheter aortic valve replacement (TAVR) has emerged as an alternative to surgical aortic valve replacement (SAVR), but unbiased data regarding evolution of the treatment of patients with aortic stenosis at the nationwide level are scarce. OBJECTIVES: This study sought to evaluate the number of aortic valve replacements (AVRs) performed in France, changes over time, and the effect of the adoption of TAVR. METHODS: Based on a French administrative hospital-discharge database, the study collected all consecutive AVRs performed in France between 2007 and 2015. RESULTS: A total of 131,251 interventions were performed: 109,317 (83%) SAVR and 21,934 (17%) TAVR. AVR linearly increased (from 10,892 to 18,704; p for trend <0.0001) mainly due to a marked increase in TAVR (from 244 to 6,722; p for trend = 0.0004), whereas SAVR remained stable (from 10,892 to 11,982; p for trend = 0.18). Parallel to a decrease in the Charlson index (p for trend <0.05), SAVR and TAVR in-hospital mortality rates significantly declined (both p for trend <0.01). The number of TAVRs significantly increased in all age categories (<75, 75 to 79, 80 to 84, and ≥85 years of age; all p for trend = 0.003), but reached or even exceeded SAVR in the 2 oldest categories. Although mortality rates declined for both isolated SAVR and TAVR, it became similar or slightly lower for TAVR than for isolated SAVR in 2015 in the 3 oldest age categories even if it did not reach statistical significance (p = 0.66, p = 0.47, and p = 0.06, respectively). CONCLUSIONS: The number of AVRs markedly increased in France between 2007 and 2015 due to the wide adoption of TAVR, which represented one-third of all AVRs in 2015. Patients' profile improved, suggesting that patients are referred earlier, and in-hospital mortality declined in all AVR subsets. Despite a worse clinical profile, the immediate outcome of TAVR compared favorably to isolated SAVR in patients >75 years of age. The results may have major implications for clinical practice and policymakers.
引用
- Nguyen V, Michel M, Eltchaninoff H, et al. Implementation of Transcatheter Aortic Valve Replacement in France. J Am Coll Cardiol. 2018. PMID: 29650117. doi:10.1016/j.jacc.2018.01.079
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。